New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
A roundup of the latest news and events from the British Association of Cosmetic Nurses
Medical aesthetic practitioners have raised safety and regulation concerns after ex-Love Island star and personal trainer Rykard Jenkins posted images on Instagram of himself training to administer botulinum toxin.
Aesthetics reports on the highlights from The Aesthetic Medicine Congress
Members of the British Association of Cosmetic Nurses (BACN) have voted unanimously to update its Code of Conduct on the training of beauty therapists.
Following positive phase 2 results from its ready-to-use liquid formulation botulinum toxin, global pharmaceutical company Galderma has received a manufacturing license from the Swedish Medical Products Agency (MPA) for a new state-of-the-art manufacturing facility at the Center of Excellence, located in Uppsala, Sweden.
Pharmaceutical company Croma Pharma has rebranded its hyaluronic acid filler brand Princess to saypha.
Global pharmaceutical company Galderma’s liquid formulation of botulinum toxin type A has achieved positive results for the treatment of glabellar lines in a phase 2 clinical trial.
Aesthetic practitioner Dr Ian Strawford has opened his third Skin Excellence Clinic in Plymouth.